The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,650.00
Ask: 1,749.00
Change: 0.00 (0.00%)
Spread: 99.00 (6.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

May And Trump To Co-Host Meeting With UK And US Business Leaders

Tue, 04th Jun 2019 07:28

LONDON (Alliance News) - Prime Minister Theresa May and US President Donald Trump will co-host a meeting of British and American business leaders in a bid to boost trade.

The prime minister plans to use the round table event on Tuesday to strengthen economic ties between the two countries.

The gathering at St James' Palace is also due to be attended by the Duke of York, Chancellor of the Exchequer Philip Hammond and International Trade Secretary Liam Fox.

US Secretary of State Mike Pompeo, US Secretary of the Treasury Steven Mnuchin and the president's daughter and assistant Ivanka Trump are expected at the meeting.

The gathering will bring together 10 leading companies, five from each nation, to discuss business opportunities and look at sectors where expanding links would benefit both sides.

Discussions are expected to focus on research, development and innovation, investment in infrastructure, and the scope for closer partnership in regulation and financial services.

Chief executives and senior representatives from BAE Systems PLC, GlaxoSmithKline PLC, National Grid PLC, Barclays PLC, Reckitt Benckiser Group PLC, JP Morgan Chase & Co, Lockheed Martin, Goldman Sachs International, Bechtel and Splunk are due to attend.

Referring to the UK-US economic relationship, the prime minister is expected to tell the meeting: "It is a great partnership, but one I believe we can make greater still.

"With a bilateral free trade agreement, with broader economic co-operation, and by continuing to work together to underpin, shape and influence the global economy and its rules and institutions – keeping markets free, fair and open, and keeping our industries competitive.

"There are opportunities to seize, and there are challenges we need to work together to tackle. Today, let us look at how we do both.

"Through dialogue like this we can ensure that our economic partnership not only endures but continues to grow stronger for many years to come – making our businesses more competitive, and creating jobs, opportunity and prosperity for all our people."

Emma Walmsley, chief executive of GSK, said: "The US is one of the most important sources of healthcare innovation in the world.

"Life sciences is also a strategic strength for the UK and there is a great opportunity for us to partner further to retain and accelerate both countries' global leadership in this sector, generating better outcomes for patients and economic growth on both sides of the Atlantic."

Roger Carr, chairman of BAE Systems, said: "Our relationship with the US of America is long-standing and operates to our mutual benefit on the firm foundation of trust, transparency and true partnership."

The US is Britain's single biggest business partner, with trade between the two countries worth GBP190 billion in 2018.

By Shaun Connolly, Press Association Political Correspondent

source: Press Association

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.